https://teapaw.org/t.co/psr7padAmX is an AI-powered precision oncology company revolutionizing liquid biopsy, single-cell multiomics & digital pathology.
India
Joined July 2025
- Tweets207
- Following6
- Followers13
- Likes30
Pinned Tweet
1Cell.Ai Inc. has been named Best Healthcare Start-Up 2026 at the 5th CII WR Health Innovation Awards.
Grateful to the clinicians, patients, and families who trust us with hard calls. This recognition strengthens our commitment to earning that trust every day. ๐
Awareness saves lives. Early detection makes a difference. ๐
This National Cancer Awareness Day, let's spread awareness and support every cancer journey.
At 1Cell.Ai, we're advancing precision oncology for better-informed cancer care.
#CancerAwarenessDay
The chemo has done its job. The scans are clear and the tumor is quiet.
.
Then comes the question patients rarely get a straight answer to:ย ย
๐๐๐๐ฉ ๐ฃ๐ค๐ฌ?ย
. #FDAApprovals #FDA #Cancer #PrecisionOncology
For HER2-+ve metastatic breast cancer, "๐ข๐๐๐ฃ๐ฉ๐๐ฃ๐๐ฃ๐๐" has meant continuing trastuzumab + pertuzumab.
On Oct 7, the FDA added a third drug: ๐ฉ๐ช๐๐๐ฉ๐๐ฃ๐๐ (๐๐ช๐ ๐ฎ๐จ๐), an oral pill that blocks HER2 from a different angle, now approved as first-line maintenance.
For HER2-+ve metastatic breast cancer, "๐ข๐๐๐ฃ๐ฉ๐๐ฃ๐๐ฃ๐๐" has meant continuing trastuzumab + pertuzumab.
On Oct 7, the FDA added a third drug: ๐ฉ๐ช๐๐๐ฉ๐๐ฃ๐๐ (๐๐ช๐ ๐ฎ๐จ๐), an oral pill that blocks HER2 from a different angle, now approved as first-line maintenance.
When ctDNA liquid biopsy in a patient is negative with suspected reoccurence; what's your next step?
#ctDNA #MRD #LiquidBiopsy #PrecisionOncology
0%trust the result
0%repeat ct-DNA in 4-6 week
0%escalate to imaging
100%consider ctc-based tests
1 votes โข Final resultsctDNA-based liquid biopsy has transformed cancer monitoring- but recent research is revealing its limits.
In a study of metastatic pancreatic cancer patients, 65% of genomic alterations were found exclusively in single-cell CTC-DNA, completely absent from matched ctDNA.
Breast cancer is India's most common cancer in women: 1.9 lakh new cases and nearly 98K deaths in 2022, the highest toll of any country.
Today, we want to thank every patient who joined a trial, endured treatment, and shared your story.
Thank you!!
#BreastCancerAwareness
On October 8, the FDA approved atezolizumab (Tecentriq) + chemotherapy after surgery for stage III dMMR colon cancer.ย
It's the first adjuvant immunotherapy approved for this group!!!
#FDAย #oncology #FDAApprovals
Same patient. Same disease. Different answers.
In leptomeningeal metastasis, CSF sequencing uncovered actionable EGFR and ERBB2 alterations missed by plasma testing, helping guide treatment decisions.
The right sample can make a critical difference. #PrecisionOncology #cancer
๐ค Made with AI
For years, frontline CLL treatment relied on one type of BTK inhibitor: drugs that bind permanently to their target.
On Oct. 2, that changed.
The FDA approved pirtobrutinib (Jaypirca) as a first-line treatment for adults with previously untreated CLL/SLL without a 17p deletion.
7/7
The question is becoming bigger than simply:
โDoes this patient have a mutation?โ
Itโs increasingly:
โHow might that mutation affect treatment resistance?โ
As frontline options evolve, could understanding the mechanism of resistance become just as important as identifying the mutation itself?
What do you think? ๐
#CLL #PrecisionOncology #BTK #CancerResearch #Oncology